Skip to content

Development of a manual to guide care for people with incontinence to prevent or treat incontinence associated dermatitis (sore skin), Part 1 and 2

PREVENTion and treatment of Incontinence-Associated Dermatitis (IAD) through optimizing care: development and feasibility of the IAD Manual (PREVENT-IAD), Part 1 and 2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN26169429
Enrollment
30
Registered
2020-02-07
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incontinence-associated dermatitis (IAD) Skin and Connective Tissue Diseases Incontinence-associated dermatitis

Interventions

The study has 3 phases. The manualized package of care (IAD Manual) will be developed and designed during phase 1 and tested during phase 3. In phase 1, 10-15 people with IAD and their carers and 10

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Experience of urinary and/or faecal incontinence with or without IAD 2. Health professional working in a care home, care agency, district nursing team, continence advisory service, tissue viability service, other community and primary care service (such as community pharmacist or GP) or as an NHS registered nurse working in secondary care with older people 3. Informal carer, family member or patient representative of those with experience of urinary and/or faecal incontinence with or without IAD

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
1. Identification of the content of a manual to guide the prevention and treatment of IAD, what might help or stop people using the manual and the training and resources that would be needed so that a manual could be introduced into care homes and the community, through focus groups at baseline 3, 6, 9 and 12 months 2. Development of a feasibility study, designed to test the efficacy of the manual and training developed in phase 1 in the prevention and treatment of IAD, through focus groups at baseline 3, 6, 9 and 12 months

Secondary

MeasureTime frame
Recruitment rates/attrition will be assessed through investigator notes at 12 months

Countries

England, United Kingdom

Contacts

Public ContactSue Woodward
sue.woodward@kcl.ac.uk+44 07941932529

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026